Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Debbie L. Wilson"'
Autor:
Khoa Nguyen, Debbie L. Wilson, Julie Diiulio, Bradley Hall, Laura Militello, Walid F. Gellad, Christopher A. Harle, Motomori Lewis, Siegfried Schmidt, Eric I. Rosenberg, Danielle Nelson, Xing He, Yonghui Wu, Jiang Bian, Stephanie A. S. Staras, Adam J. Gordon, Jerry Cochran, Courtney Kuza, Seonkyeong Yang, Weihsuan Lo-Ciganic
Publikováno v:
Bioelectronic Medicine, Vol 10, Iss 1, Pp 1-14 (2024)
Abstract Background Integrating advanced machine-learning (ML) algorithms into clinical practice is challenging and requires interdisciplinary collaboration to develop transparent, interpretable, and ethically sound clinical decision support (CDS) to
Externí odkaz:
https://doaj.org/article/f82f1a8f2e584031b422e4a83946c927
Autor:
Debbie L. Wilson, Shubha Kollampare, C. Kent Kwoh, Lili Zhou, Erin L. Ashbeck, Dominick Sudano, Maria Lupi, Andrew Miller, Kristy Smith, Wei‐Hsuan Lo‐Ciganic
Publikováno v:
ACR Open Rheumatology, Vol 6, Iss 6, Pp 380-387 (2024)
Objective We aimed to estimate Coccidioides serologic screening rates before initiation of biologic disease‐modifying antirheumatic drugs including tofacitinib (b/tsDMARDs), conventional synthetic disease‐modifying antirheumatic drugs (csDMARDs),
Externí odkaz:
https://doaj.org/article/06d5f485506a41ffb150166b62997bc3
Autor:
Debbie L. Wilson, Lili Zhou, Dominick G. Sudano, Erin L. Ashbeck, C. Kent Kwoh, Lindy Krebs, Amy Sheer, James Smith, Michael Tudeen, Wei‐Hsuan Lo‐Ciganic
Publikováno v:
ACR Open Rheumatology, Vol 6, Iss 5, Pp 287-293 (2024)
Objective The study objective was to examine associations between the use of biologic response modifiers (BRMs), corticosteroids, and oral small molecules (OSMs) and subsequent coccidioidomycosis infection risk among US Medicare beneficiaries with rh
Externí odkaz:
https://doaj.org/article/a259bb3f75a2434badba39ad14d1819e
Autor:
Haesuk Park, Carolyn Brown, Debbie L. Wilson, Pei-Lin Huang, Pilar Hernández-Con, Patrick Horne, Amie Goodin, Amanda Joseph, Rich Segal, Roniel Cabrera, Robert L. Cook
Publikováno v:
Preventive Medicine Reports, Vol 32, Iss , Pp 102138- (2023)
The likelihood of clinicians prescribing direct-acting antiviral (DAA) therapy for patients with chronic hepatitis C virus (HCV) and substance use disorder (SUD) was assessed via a survey emailed throughout the United States to clinicians (physicians
Externí odkaz:
https://doaj.org/article/b7d45ca4180645e6aa279270b2bb95f8
Autor:
Amie J. Goodin, Debbie L. Wilson, Robert L. Cook, Yan Wang, Joshua Brown, Almut G. Winterstein
Publikováno v:
Medical Cannabis and Cannabinoids, Pp 1-4 (2021)
The Cannabis Clinical Outcomes Research Conference (CCORC) 2021 was held virtually on April 8 and 9, 2021. The conference was hosted by the Consortium for Medical Marijuana Clinical Outcomes Research, a research organization instituted by the state l
Externí odkaz:
https://doaj.org/article/e3cbc2b9994e40cfa3038f3f75155bdd
Autor:
Ching-Yuan Chang, Haesuk Park, Juan M Hincapie-Castillo, Coy D Heldermon, Vakaramoko Diaby, Seonkyeong Yang, Debbie L Wilson, Wei-Hsuan Lo-Ciganic
Publikováno v:
Journal of Managed Care & Specialty Pharmacy. 29:431-445
Publikováno v:
Value in Health. 25:1328-1335
This study examined health preference utility weights and utility decrements associated with different types of chronic conditions in the United States.We used the 2010-2015 Medical Expenditure Panel Survey data for persons aged ≥ 18 years with 12-
Autor:
Xinyi Jiang, Hyun Jin Song, Ching-Yuan Chang, Debbie L. Wilson, Wei-Hsuan Lo-Ciganic, Haesuk Park
Publikováno v:
Medical Care.
Autor:
Wei‐Hsuan Lo‐Ciganic, Juan Hincapie‐Castillo, Ting Wang, Yong Ge, Bobby L. Jones, James L. Huang, Ching‐Yuan Chang, Debbie L. Wilson, Jeannie K. Lee, Gary M. Reisfield, Chian K. Kwoh, Chris Delcher, Khoa A. Nguyen, Lili Zhou, Ronald I. Shorr, Jingchuan Guo, Zachary A. Marcum, Christopher A. Harle, Haesuk Park, Almut Winterstein, Seonkyeong Yang, Pei‐Lin Huang, Lauren Adkins, Walid F. Gellad
Publikováno v:
Addiction. 117:1982-1997
One-third of opioid (OPI) overdose deaths involve concurrent benzodiazepine (BZD) use. Little is known about concurrent opioid and benzodiazepine use (OPI-BZD) most associated with overdose risk. We aimed to examine associations between OPI-BZD dose
Autor:
Shu Huang, Motomori O. Lewis, Yuhua Bao, Prakash Adekkanattu, Lauren E. Adkins, Samprit Banerjee, Jiang Bian, Walid F. Gellad, Amie J. Goodin, Yuan Luo, Jill A. Fairless, Theresa L. Walunas, Debbie L. Wilson, Yonghui Wu, Pengfei Yin, David W. Oslin, Jyotishman Pathak, Wei-Hsuan Lo-Ciganic
Publikováno v:
Journal of clinical medicine. 11(16)
Suicide is a leading cause of death in the US. Patients with pain conditions have higher suicidal risks. In a systematic review searching observational studies from multiple sources (e.g., MEDLINE) from 1 January 2000–12 September 2020, we evaluate